Scleroderma (also known as systemic sclerosis) is a rheumatologic disease that results in chronic hardening and tightening of connective tissues. Our program comprises doctors from rheumatology, allergy & clinical immunology, pulmonary critical care, cardiology gastroenterology, nephrology, and dermatology with special expertise in scleroderma.
The team provides coordinated, multidisciplinary, and compassionate care for patients and all the parts of the body scleroderma affects, including the skin, lung, heart, kidneys, and gastrointestinal system. We also address functional, nutritional, psychological, gynecological, urological, and/or sexual health challenges. The goal is improved quality of life, enhanced patient satisfaction, and better outcomes.
The research program in scleroderma is geared towards identifying new treatments. Our ultimate goal is to cure scleroderma. In order to accomplish this, expert doctors in clinic partner with world class scientists at the benchtop.
Yale has been designated as a Scleroderma Center by the Scleroderma Foundation.